Virtu Financial’s NeoGenomics NEO Stock Holding History

Virtu Financial’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$150K	Buy	+20,234	New	+$213K	0.01%	1103
2025 Q4	–	Sell	-28,987	Closed	-$224K	–	2039
2025 Q3	$224K	Buy	28,987 +16,991	+142%	+$119K	0.01%	867
2025 Q2	$88K	Buy	+11,996	New	+$96.8K	﹤0.01%	1055
2023 Q2	–	Sell	-17,404	Closed	-$303K	–	1850
2023 Q1	$303K	Buy	+17,404	New	+$248K	0.03%	544
2022 Q2	–	Sell	-37,001	Closed	-$450K	–	1903
2022 Q1	$450K	Buy	37,001 +28,752	+349%	+$605K	0.03%	429
2021 Q4	$281K	Buy	+8,249	New	+$323K	0.03%	662
2019 Q4	–	Sell	-15,284	Closed	-$292K	–	1708
2019 Q3	$292K	Buy	15,284 +2,839	+23%	+$66.6K	0.02%	777
2019 Q2	$273K	Buy	+12,445	New	+$273K	0.02%	835

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Virtu Financial's NEO Position: Q1 2026 in Review

Virtu Financial opened a new position in NeoGenomics (NEO) in Q1 2026: 20,234 shares worth $150K. The stake represents 0.01% of the portfolio and ranks #1103 among its holdings. This is a return to the name: Virtu Financial previously reported a position in NEO as recently as Q3 2025.

Virtu Financial first reported a position in NEO in Q2 2019 and has held it in 8 quarters since. The position peaked at $450K in Q1 2022. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Virtu Financial held 20,234 shares of NeoGenomics worth $150K as of Q1 2026.
NeoGenomics was a new Virtu Financial position in Q1 2026.
NeoGenomics made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #1103 holding.
Virtu Financial first reported a position in NeoGenomics in Q2 2019 and has held it in 8 quarters since.
Virtu Financial's NeoGenomics position peaked at $450K in Q1 2022.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.